Assessment of the relationship between lipid parameters and obesity indices in non-diabetic obese patients: A preliminary report

Medical Science Monitor

Volumn 20, Issue , 2014, Pages 2683-2688

  Stępień, Anna ^a   Stępień, Mariusz ^a   Wlazeł, Rafał N ^a   Paradowski, Marek ^a   Banach, Maciej ^a   Rysz, Jacek ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Dyslipidemias; Obesity; Therapeutics

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROTROPIN; TRIACYLGLYCEROL; LIPID;

ADULT; ARTICLE; BLOOD CELL COUNT; BODY ADIPOSITY INDEX; BODY MASS; CROSS-SECTIONAL STUDY; DIAGNOSTIC PROCEDURE; DYSLIPIDEMIA; FEMALE; GLUCOSE TOLERANCE TEST; HIP CIRCUMFERENCE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; KIDNEY FUNCTION; LIPID ANALYSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; URINALYSIS; VISCERAL ADIPOSITY INDEX; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WAIST TO HEIGHT RATIO; BLOOD; DIABETES MELLITUS;

DIABETES MELLITUS; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; OBESITY;

EID: 84918534983     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.890845     Document Type: Article

References (31)

1. Schneider HJ, Friedrich N, Klotsche J et al: The predictive value of difer-ent measures of obesity for incident cardiovascular events and mortality. J Clin Endocrinol Metab, 2010; 95: 1777–85
2. Stępień M, Wlazeł RN, Paradowski M et al: Serum concentrations of adipo-nectin, leptin, resistin, ghrelin and insulin and their association with obesity indices in obese normo- and hypertensive patients – pilot study. Arch Med Sci, 2012; 8(3): 431–36
3. Stepien M, Rosniak-Bak K, Paradowski M et al: Waist circumference, ghre-lin and selected adipose tissue-derived adipokines as predictors of insulin resistance in obese patients: preliminary results. Med Sci Monit, 2011; 17(11): PR13–18
4. Nikolic D, Nikfar S, Salari P et al: Lipid and Blood Pressure Meta-Analysis Collaboration Group. Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials. Curr Med Res Opin, 2013; 29: 435–51
5. Gundogan K, Bayram F, Gedik V et al: Metabolic syndrome prevalence according to ATP III and IDF criteria and related factors in Turkish adults. Arch Med Sci, 2013; 9(2): 243–53
6. Bays HE, Toth PP, Kris-Etherton PM et al: Obesity, adiposity, and dyslipid-emia: A consensus statement from the National Lipid Association. J Clin Lipidol, 2013; 7(4): 304–83
7. Blumentals WA, Hwu P, Kobayashi N, Ogura E: Obesity in hospitalized type 2 diabetes patients: A descriptive study. Med Sci Monit, 2013; 19: 359–65
8. Karakaş P, Bozkır MG: Anthropometric indices in relation to overweight and obesity among Turkish medical students. Arch Med Sci, 2012; 8(2): 209–13
9. Rizzo M, Banach M, Montalto G, Mikhailidis DP: Lipid-lowering therapies and achievement of LDL-cholesterol targets. Arch Med Sci, 2012, 8(4): 598–600
10. Banach M, Mikhailidis DP, Kjeldsen SE, Rysz J: Time for new indications for statins? Med Sci Monit, 2009; 15(12): MS1–5
11. Barylski M, Małyszko J, Rysz J et al: Lipids, blood pressure, kidney – what was new in 2011? Arch Med Sci, 2011; 7: 1055–66
12. de Koning L, Merchant AT, Pogue J, Anand SS: Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J, 2007; 28: 850–56
13. Amato MC, Giordano C, Galia M et al: and for the Alka MeSy Study Group. Visceral Adiposity Index. A reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care, 2010; 33: 920–22
14. Bozorgmanesh M, Hadaegh F, Azizi F: Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: Type 2 Diabetes. Lipids Health Dis, 2011; 10: 88
15. Bergman RN, Stefanovski D, Buchanan TA et al: A better index of body adiposity. Obesity, 2011; 19: 1083–89
16. Knowles KM, Paiva LL, Sanchez SE et al: Waist circumference, body mass index, and other measures of adiposity in predicting cardiovascular disease risk factors among Peruvian adults. Int. J. Hypertens, 2011; article ID 931402
17. Stępień M, Stępień A, Wlazeł RN et al: Obesity indices and adipokines in non-diabetic obese patients with early stages of chronic kidney disease. Med Sci Monit, 2013; 19: 1063–72
18. Stepien M, Stepien A, Banach M et al: New obesity indices and adipokines in normotensive patients and patients with hypertension: comparative pilot analysis. Angiology, 2014; 65(4): 333–42
19. Lee CM, Huxley RR, Widma RP et al: Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analy-sis. J Clin Epidem, 2008; 61: 646–53
20. Huxley R, Mendis S, Zheleznyakov E et al: Body mass index, waist circumference and waist: hip ratio as predictors of cardiovascular risk – a review of the literature. Eur J Clin Nutr, 2010; 64: 16–22
21. Vujovic A1, Kotur-Stevuljevic J, Spasic S et al: Evaluation of diferent formulas for LDL-C calculation. Lipids in Health and Disease, 2010, 9: 27–36
22. Marotta T, Russo BF, Ferrara LA: Triglyceride-to-HDL-C-cholesterol ratio and metabolic syndrome as contributors to cardiovascular risk in overweight patients. Obesity, 2010; 18: 1608–13
23. Tomasik T, Jozwiak J, Windak A et al: Prevention of coronary heart disease in primary medical care in Poland: results from the LIPIDOGRAM study. Eur J Cardiovasc Prev Rehabil, 2011; 18: 287–96
24. Pająk A, Wiercińska E, Polakowska M et al: Occurrence of dyslipidemias in males and females aged 20–70 years in Poland. Results of WOBASZ trial [Polish]. Kardiol Pol, 2005; 63(Suppl.4): S1–S6
25. Mastej M, Jóźwiak J, Lukas W et al: Assessment and comparison of lipid parameters according to sex and body mass index BMI. Lipidogram 2004. Lipidogram 5 years [Polish]. Kardiol Pol, 2006; 64(Suppl.2): 153–60
26. Howard BV, Ruotolo G, Robbins DC: Obesity and dyslipidemia. Endocrinol Metab Clin N Am, 2003; 32: 855–67
27. Hu D, Hannah J, Gray RS et al: Effects of obesity and body fat distribution on lipids and lipoproteins in nondiabetic American Indians: The Strong Heart Study. Obes Res, 2000; 8: 411–21
28. Gruson E, Montaye M, Kee F et al: Anthropometric assessment of abdominal obesity and coronary heart disease risk in men: the PRIME study. Heart, 2010; 96: 36–40
29. Unek IT, Bayraktar F, Solmaz D et al: The levels of soluble CD40 ligand and C-reactive protein in normal weight, overweight and obese people. Clin Med Res, 2010; 2: 89–95
30. Mojiminiyi OA, Al Mulla F, Abdella NA: Which obesity index best explains the link between adipokines, coronary heart disease risk and metabolic abnormalities in type 2 diabetes mellitus? Medic Princ Pract, 2009; 18: 123–29
31. Chehrei A, Sadrnia S, Keshteli AH et al: Correlation of dyslipidemia with waist to height ratio, waist circumference, and body mass index in Iranian adults. Asia Pac J Clin Nutr, 2007; 16: 248–53